DE60008712D1 - Verfahren zur detektion von endometriosis - Google Patents

Verfahren zur detektion von endometriosis

Info

Publication number
DE60008712D1
DE60008712D1 DE60008712T DE60008712T DE60008712D1 DE 60008712 D1 DE60008712 D1 DE 60008712D1 DE 60008712 T DE60008712 T DE 60008712T DE 60008712 T DE60008712 T DE 60008712T DE 60008712 D1 DE60008712 D1 DE 60008712D1
Authority
DE
Germany
Prior art keywords
detecting
eosinophil peroxidase
component
treating endometriosis
targeting molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60008712T
Other languages
English (en)
Inventor
D Blumenthal
M Goldenberg
Michael Samoszuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY BELLEVILLE
Center for Molecular Medicine and Immunology
Original Assignee
CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY BELLEVILLE
Center for Molecular Medicine and Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY BELLEVILLE, Center for Molecular Medicine and Immunology filed Critical CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY BELLEVILLE
Application granted granted Critical
Publication of DE60008712D1 publication Critical patent/DE60008712D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6871—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an enzyme
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1075—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
DE60008712T 1999-04-02 2000-03-31 Verfahren zur detektion von endometriosis Expired - Lifetime DE60008712D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12747799P 1999-04-02 1999-04-02
PCT/US2000/008581 WO2000059547A2 (en) 1999-04-02 2000-03-31 Method of detecting endometriosis

Publications (1)

Publication Number Publication Date
DE60008712D1 true DE60008712D1 (de) 2004-04-08

Family

ID=22430337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60008712T Expired - Lifetime DE60008712D1 (de) 1999-04-02 2000-03-31 Verfahren zur detektion von endometriosis

Country Status (8)

Country Link
US (1) US6540980B1 (de)
EP (1) EP1169064B1 (de)
JP (1) JP2002541124A (de)
AT (1) ATE260678T1 (de)
AU (1) AU4056000A (de)
CA (1) CA2366774A1 (de)
DE (1) DE60008712D1 (de)
WO (1) WO2000059547A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833528B2 (en) * 1998-06-22 2010-11-16 Immunomedics, Inc. Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
US6962702B2 (en) * 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7138103B2 (en) * 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
DK2270149T3 (en) * 1999-04-09 2016-05-09 Kyowa Hakko Kirin Co Ltd PROCEDURE TO CONTROL THE ACTIVITY OF IMMUNOLOGICAL FUNCTIONAL MOLECULE.
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
AU2003249742A1 (en) * 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
WO2004082626A2 (en) * 2003-03-18 2004-09-30 Ethicon, Inc. Aromatase inhibitor diagnosis and therapy
US20050155097A1 (en) * 2004-01-12 2005-07-14 Lee James J. Eosinophil-deficient transgenic animals
US20060008876A1 (en) 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
KR101206318B1 (ko) * 2004-10-28 2012-11-29 교와 핫꼬 기린 가부시키가이샤 자궁 내막증 치료제
JP2009521512A (ja) * 2005-12-23 2009-06-04 ザ バーナム インスティテュート フォー メディカル リサーチ 子宮内膜症細胞ターゲティングペプチドおよびその使用
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
WO2010124101A2 (en) * 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
WO2011126984A1 (en) * 2010-04-05 2011-10-13 University Of Utah Research Foundation Mapping in vivo eosinophil activation in eosinophilic esophagitis
LT2790668T (lt) 2011-12-13 2020-12-28 Engeneic Molecular Delivery Pty Ltd. Iš bakterijų gautos, nepažeistos miniląstelės, skirtos terapinių agentų pristatymui į smegenų navikus
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
GB202202919D0 (en) 2022-03-02 2022-04-13 Serac Healthcare Ltd Methods for imaging integrin expression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782840A (en) * 1984-03-02 1988-11-08 Neoprobe Corporation Method for locating, differentiating, and removing neoplasms
US4932412A (en) * 1986-12-18 1990-06-12 Immunomedics, Inc. Intraoperative and endoscopic tumor detection and therapy
US5478725A (en) * 1992-06-12 1995-12-26 University Of Pennsylvania αv β3 integrin as a predictor of endometriosis
US5843673A (en) * 1994-10-25 1998-12-01 Curators Of The University Of Missouri Method of screening for endometriosis
US5831035A (en) * 1994-10-25 1998-11-03 Curators Of The University Of Missouri Antibody against human endometrial stromal cell glycoprotein
US5567828A (en) 1995-06-07 1996-10-22 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side
CA2214196A1 (en) 1996-09-26 1998-03-26 Eli Lilly And Company Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods

Also Published As

Publication number Publication date
EP1169064A2 (de) 2002-01-09
WO2000059547A3 (en) 2001-07-26
CA2366774A1 (en) 2000-10-12
EP1169064B1 (de) 2004-03-03
JP2002541124A (ja) 2002-12-03
ATE260678T1 (de) 2004-03-15
AU4056000A (en) 2000-10-23
US6540980B1 (en) 2003-04-01
WO2000059547A2 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
ATE260678T1 (de) Verfahren zur detektion von endometriosis
DE69914138D1 (de) System, gerät und verfahren zur positionsbestimmung von meerestieren
DE60220251D1 (de) Nadelfreie injektionsvorrichtung für den einmaligen gebrauch und verfahren dafür
DE10085388T1 (de) Verfahren und Vorrichtung zur Adressuche längster Übereinstimmung
DE60022304D1 (de) Verfahren und Anordnung zur Ortung von Sprechern
ATE520466T1 (de) Apparat und verfahren zur modifizierung von magnetisch inmmobilizierte biomolekulen
MXPA02001697A (es) Aparato y metodo para localizar la fuente de una senal desconocida.
DE60106854D1 (de) Verfahren und Vorrichtung zur Elektroentionisierung von Wasser
DE60026767D1 (de) System und Verfahren zum Lernen von Benutzerpräferenzen
ATE277671T1 (de) Vorrichtung zur verbesserung der transdermalen abnahme von körperflüssigkeiten
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
DE60025368D1 (de) Verfahren zum identifizieren von prostaglandin d2 rezeptor modulatoren
DE60208278D1 (de) System und Verfahren zum Testen von Nukleinsäuremolekülen
DE69904525D1 (de) Verfahren zur Generierung von Pseudo-Zufallszahlen
DE69942742D1 (de) Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs
DE50114839D1 (de) Aktiver magnetfeldsensor, dessen verwendung, verfahren und vorrichtung
DE69829625D1 (de) Verfahren und Vorrichtung zur Behandlung von Perfluorokohlenstoff
DE69826797D1 (de) Verfahren zur Generierung von Korrekturtabellen zur Detektion von Fehlzündungen mittels neuronaler Netzwerke
ATE343788T1 (de) Verfahren zum simultanen nachweis von beiden gliedern eines bindungspaares
DE60038478D1 (de) Vorrichtung zur Injektion von Kontrastmitteln
DE60141965D1 (de) Verfahren und vorrichtung für artilleriegeschosse
DE69810416T2 (de) Verfahren und Vorrichtung zur Verbesserung der Verpflanzung von Sämlingen
DE59913841D1 (de) EEPROM und Verfahren zur Ansteuerung eines EEPROM
DE69820804D1 (de) Vorrichtung und Verfahren zur Reinigung von polymerisierbaren organischen Komponenten
DE69841054D1 (de) Abwasserozonisierung Verfahren und Vorrichtung

Legal Events

Date Code Title Description
8332 No legal effect for de